Navigation Links
Bradmer announces management changes
Date:10/3/2007

Based on this experience, Dr. Ahmad has a strong working knowledge of cGMP and CMC documentation for IND and BLA preparation. From an academic perspective, Dr. Ahmad held the position of Senior Scientist/Assistant Professor at Indiana University, and was a Visiting Fellow at the National Institutes of Health in Bethesda, MD. He received his Ph.D in Biochemistry from Aligarh University in India. He has published numerous peer reviewed articles including nine papers in the Journal of Biological Chemistry.

About Bradmer Pharmaceuticals Inc. (http://www.bradmerpharma.com)

Bradmer Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new and innovative cancer therapies. Bradmer's lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer, glioblastoma multiforme. To date, over US$60 million in grants and related support has driven research and development of the licensed treatment, which has been delivered to over 200 patients with promising results and has completed Phase II clinical trials at Duke University. Bradmer is currently in the process of organizing a prospective multi-center clinical trial of the licensed treatment. Neuradiab has been granted Orphan Drug Status by both the U.S. Food and Drug Administration and the European Medicines Agency.

Bradmer Pharmaceuticals Inc.'s common shares have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state regulatory agency in the United States. The resale or transfer by a U.S. investor of such common shares of Bradmer Pharmaceuticals Inc. is subject to the requirements of Rule 904 of Regulation S of the Securities Act or such other applicable exemption thereunder, and other applicable state securities laws.

Except for historical information, this press
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 The federal ... ) in the U.S. District Court, District ... for plaintiff medical information covered by the federal ... the July 16th Order, U.S. District Judge Douglas ... Fresenius Medical Care the right to receive HIPAA- ...
(Date:7/24/2014)... American Society of Association Executives (ASAE) announced its 2014 ... of the American Society of Anesthesiologists (ASA). , ... Power of A Gold Award, one of the top ... the betterment of the world through education on the ... improve anesthesia care. , ASA was also honored with ...
(Date:7/24/2014)... July 24, 2014 Pools and beaches are ... water can be dangerous, especially for small children, so ... safety. , According to the Centers for Disease Control and ... most at risk for water-related injuries and deaths. It’s important ... around water, so Amica is offering the following tips from ...
(Date:7/24/2014)... News Facts , Lexmark’s ... certification for compliance with Department of Defense (DoD) ... DoD Information Assurance Certification and Accreditation Process (DIACAP). ... the DoD as the Enterprise Clinical Imaging Archive, ... the U.S. Army Medical Materiel Agency. , DIACAP ...
(Date:7/24/2014)... July 24, 2014 A new study led ... into the interplay among bacteria, viruses and the immune ... men,s infectivity their potential to infect others ... produce large amounts of virus in their semen despite ... "compartmentalization," where different levels of the virus can be ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 3Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 4Health News:TGen-led study seeks to understand why some HIV-positive men are more infectious 2
... may pride themselves on being highly evolved, most still ... choosing a mate, according to research by Indiana University ... and colleagues found that though individuals may claim otherwise, ... the much choosier of the sexes, leverage their looks ...
... the religious beliefs and practices of American physicians has ... is psychiatry. Among psychiatrists who have a religion, more ... are Protestant or Catholic, the two most common religions ... September 2007 issue of Psychiatric Services, also found that ...
... 12 to 19 years who received family-based treatment were ... those who received supportive psychotherapy, which explores the underlying ... the September issue of Archives of General Psychiatry, one ... a disabling eating disorder with a prevalence of 1 ...
... Deer Run, 360 White Deer Run Road, ... Treatment Gap of One Million Needing Treatment vs. 90,000 ... Obtaining Help, WDR Parent CRC Health Group CEO Dr. ... Officials, State Representatives, HARRISBURG, Pa., ...
... September 3 - QUANTEL has Entered Into ... the Company WaveLight Aesthetic GmbH A strong complementarity ... WaveLight AG, is,specialized in Dermatology/Aesthetic lasers. It is based ... estimated of approx. 10MEUR,for the fiscal year 2006/2007 ended ...
... schizophrenia, INDIANAPOLIS, Sept. 2 An investigational,phase II ... for the first time in humans a drug that ... antipsychotic activity. The study,was sponsored by Eli Lilly and ... - a randomized, double-blind, placebo-controlled clinical,trial - patients were ...
Cached Medicine News:Health News:Choosing a mate: what we really want 2Health News:Psychiatrists are the least religious of all physicians 2Health News:Psychiatrists are the least religious of all physicians 3Health News:Family-based treatment more effective than supportive psychotherapy in treating bulimia 2Health News:4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA 'National Model' Detox Center 2Health News:QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 3Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 4Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 5Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 6
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
(Date:7/24/2014)... Ohio, July 24, 2014  Mettler-Toledo International Inc. (NYSE: ... for 2014.  Provided below are the highlights: ... the quarter compared with the prior year. Reported sales ... , Net earnings per diluted share as reported ... quarter of 2013. Adjusted EPS was $2.57, an increase ...
(Date:7/24/2014)... THOUSAND OAKS, Calif. , July 24, 2014 ... will report its second quarter financial results on Tuesday, July ... The announcement will be followed by a conference call with ... call from Amgen will be Robert A. Bradway , ... senior management team. Live audio of the conference ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
... Facility, VIENNA, Va., Aug. 14 CEL-SCI CORPORATION,(Amex: ... into an agreement with a,biomedical real estate group under ... facility for its cancer drug Multikine(R). The,financial value of ... is located near Baltimore, Maryland. Once fully built out ...
... ALTO, Calif., Aug. 15 CV Therapeutics,Inc. (Nasdaq: ... developed jointly,by the American College of Cardiology Foundation ... week,s issue of Circulation, state that,"ranolazine may be ... Ranexa(R) (ranolazine extended-release tablets) is indicated for the,treatment ...
Cached Medicine Technology:CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 2CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 3CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug 4Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI) 2
Steroid-eluting, screw-in pacing lead...
... one of the world's thinnest, ... a 7 F introducer, the ... designed to lower the incidence ... introduction in smaller, more tortuous ...
... Vitatron Crystalline Active fixation lead series ... new extendable retractable helix mechanism, specifically ... the pacemaker system, reducing the sensing ... The Crystalline Active fixation leads allow ...
... 6491 unipolar pediatric temporary pacing ... atrial and ventricular sensing and ... surgery. This temporary pacing lead ... the ideal lead for pediatric ...
Medicine Products: